These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2884554)

  • 1. Beta-blockers: a new therapeutic approach to Raynaud's disease.
    Brotzu G; Susanna F; Roberto M; Palmina P
    Microvasc Res; 1987 Mar; 33(2):283-8. PubMed ID: 2884554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of presynaptic beta-receptors in Raynaud's disease.
    Brotzu G; Carboni MG; Falchi S; Montisci R; Petruzzo P
    Artery; 1985; 13(2):77-86. PubMed ID: 3002305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raynaud's phenomenon as side effect of beta-blockers in hypertension.
    Marshall AJ; Roberts CJ; Barritt DW
    Br Med J; 1976 Jun; 1(6024):1498-9. PubMed ID: 6109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
    Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of presynaptic beta receptors in Raynaud's disease.
    Brotzu G; Falchi S; Mannu B; Montisci R; Petruzzo P; Staico R
    J Vasc Surg; 1989 Jun; 9(6):767-71. PubMed ID: 2542629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta blockers and disturbances of the microcirculation (author's transl)].
    Cloarec M; Graisely B; Dumas R; Chermet J; Gilbert JC; Debray J
    J Mal Vasc; 1980; 5(2):123-4. PubMed ID: 6109751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha and beta-blockade and beta-stimulation in Raynaud's syndrome: a double-blind, placebo controlled, single dose study.
    Cleophas TJ; Fennis JF; van 't Laar A
    Angiology; 1985 Apr; 36(4):219-25. PubMed ID: 2862814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Raynaud's syndrome with adrenergic alpha-blockade with or without beta-blockade.
    Cleophas TJ; van Lier HJ; Fennis JF; van 't Laar A
    Angiology; 1984 Jan; 35(1):29-37. PubMed ID: 6141750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Raynaud's phenomenon as side effect of beta-blockers.
    Marshall A; Barritt DW; Roberts CJ
    Br Med J; 1976 Jul; 2(6030):301. PubMed ID: 8186
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective antagonism of S2-serotonergic receptors relieves but does not prevent cold induced vasoconstriction in primary Raynaud's phenomenon.
    Seibold JR; Terregino CA
    J Rheumatol; 1986 Apr; 13(2):337-40. PubMed ID: 2941573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic blockade and vasospasm.
    Thulesius O
    Acta Med Scand Suppl; 1979; 625():41-3. PubMed ID: 34980
    [No Abstract]   [Full Text] [Related]  

  • 12. Nicardipine in the treatment of Raynaud's phenomenon. Dissociation of platelet activation from vasospasm.
    Wigley FM; Wise RA; Malamet R; Scott TE
    Arthritis Rheum; 1987 Mar; 30(3):281-6. PubMed ID: 2952125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: prediction of the efficacy of beta-blockade therapy and interest of unilateral adrenalectomy.
    Mazzuco TL; Chaffanjon P; Martinie M; Sturm N; Chabre O
    Endocr J; 2009; 56(7):867-77. PubMed ID: 19564707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial.
    Colombo M; de Franchis R; Tommasini M; Sangiovanni A; Dioguardi N
    Hepatology; 1989 Mar; 9(3):433-8. PubMed ID: 2563985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thermosensitivity of cutaneous vessels and Raynaud's disease].
    Vanhoutte PM; De Mey C; Janssens WJ
    Rev Med Liege; 1980 Oct; 35(19):634-9. PubMed ID: 6109368
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-blocker brain concentrations in man.
    Cruickshank JM; Neil-Dwyer G
    Eur J Clin Pharmacol; 1985; 28 Suppl():21-3. PubMed ID: 2865144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of different beta-blockers in the treatment of long QT syndrome.
    Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ
    J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension.
    Fodor JG; Chockalingam A; Drover A; Fifield F; Pauls CJ
    J Clin Pharmacol; 1987 Nov; 27(11):892-901. PubMed ID: 2892865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.
    de Graaf M; Raphael MF; Breugem CC; Knol MJ; Bruijnzeel-Koomen CA; Kon M; Breur JM; Pasmans SG
    J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1732-40. PubMed ID: 24011909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.